These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6439851)
21. Effect of DN-1417, a thyrotropin releasing hormone analog, on dopaminergic neurons in rat brain. Nakahara T; Matsumoto T; Hirano M; Uchimura H; Yokoo H; Nakamura K; Ishibashi K; Hirano H Peptides; 1985; 6(6):1093-9. PubMed ID: 3938840 [TBL] [Abstract][Full Text] [Related]
22. Long-term increase in striatal thyrotropin-releasing hormone receptor binding caused by amygdaloid kindling. Kajita S; Ogawa N; Sato M Epilepsia; 1987; 28(3):228-33. PubMed ID: 3034560 [TBL] [Abstract][Full Text] [Related]
23. [TRH and its analog (DN-1417). Effects on central dopaminergic system-dependent behaviors in rats and mice]. Miyamoto M; Saji Y; Nagawa Y Nihon Yakurigaku Zasshi; 1985 Mar; 85(3):129-41. PubMed ID: 3924793 [TBL] [Abstract][Full Text] [Related]
24. [Effect of DN-1417 on ataxia in Rolling mouse Nagoya and Staggerer mouse in comparison with the effect of TRH]. Matsui K; Mano Y; Ando K Yakubutsu Seishin Kodo; 1986 Jun; 6(2):281-3. PubMed ID: 3096012 [TBL] [Abstract][Full Text] [Related]
25. [A TRH analog (DN-1417). Antagonistic effects on reserpine-induced decreases in local cerebral glucose utilization and cerebral monoamine levels]. Nagai Y; Narumi S; Saji Y; Nagawa Y Nihon Yakurigaku Zasshi; 1985 May; 85(5):315-26. PubMed ID: 3928465 [TBL] [Abstract][Full Text] [Related]
26. Lack of usefulness of DN-1417 for characterization of a CNS receptor for thyrotropin-releasing hormone. Hawkins EF; Wade R; Engel WK J Neurochem; 1987 Jul; 49(1):239-45. PubMed ID: 3035097 [TBL] [Abstract][Full Text] [Related]
27. Thyrotropin-releasing hormone (TRH) and its analog (DN-1417): interaction with pentobarbital in choline uptake and acetylcholine synthesis of rat brain slices. Narumi S; Nagai Y; Miyamoto M; Nagawa Y Life Sci; 1983 Apr; 32(14):1637-45. PubMed ID: 6403792 [TBL] [Abstract][Full Text] [Related]
28. A TRH analog (DN-1417): motor stimulation with rearing related to catecholaminergic mechanisms in rats. Miyamoto M; Narumi S; Nagai Y; Saji Y; Nagawa Y Neuropharmacology; 1984 Jan; 23(1):61-72. PubMed ID: 6425711 [TBL] [Abstract][Full Text] [Related]
29. Effects of TRH and TRH analogues on the central regulation of breathing in the rat. Hedner J; Hedner T; Wessberg P; Lundberg D; Jonason J Acta Physiol Scand; 1983 Mar; 117(3):427-37. PubMed ID: 6410685 [TBL] [Abstract][Full Text] [Related]
30. Ventral root depolarization and spinal reflex augmentation by a TRH analog in rat spinal cord. Ono H; Fukuda H Neuropharmacology; 1982 Aug; 21(8):739-44. PubMed ID: 6811965 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
33. [A TRH analog (DN-1417). Anti-reserpine action in electroconvulsive threshold and involvement of serotonergic (5-HT) mechanism in mice]. Nagai Y; Narumi S; Saji Y; Nagawa Y Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):221-30. PubMed ID: 3924796 [TBL] [Abstract][Full Text] [Related]
34. Effect of TRH analog (DN-1417) on tyrosine hydroxylase activity in mesocortical, mesolimbic and nigrostriatal dopaminergic neurons of rat brain. Yokoo H; Nakahara T; Matsumoto T; Inanaga K; Uchimura H Peptides; 1987; 8(1):49-53. PubMed ID: 2883633 [TBL] [Abstract][Full Text] [Related]
35. [Effect of (-)-N-[(S)-hexahydro-l-methyl-2, 6-dioxo-4-pyrimidinylcarbonyl]-L-histidyl-L-prolinamide (TA-0910), a new TRH analog, on plasma levels of TSH and thyroid hormones in rats]. Moriyasu M; Nasu M; Honda H; Sakamoto T; Yamamura M; Matsuoka Y Nihon Yakurigaku Zasshi; 1996 Jun; 107(6):285-97. PubMed ID: 8690309 [TBL] [Abstract][Full Text] [Related]
36. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
37. Lack of interaction between thyrotropin releasing hormone and its analogs with 3H-quinuclidinyl benzilate recognition sites in the rat striatum. Das S; Bhargava HN Neuropharmacology; 1985 Jul; 24(7):681-3. PubMed ID: 3927185 [TBL] [Abstract][Full Text] [Related]
38. Effects of YM-14673, a new thyrotropin-releasing hormone analogue, on impaired learning of passive avoidance in mice. Yamamoto M; Ozawa Y; Takeuchi H Arch Int Pharmacodyn Ther; 1993; 321():5-13. PubMed ID: 8100705 [TBL] [Abstract][Full Text] [Related]
39. Determination of L-6-keto-piperidine-2-carbonyl-L-leucyl-L-proline amide (RGH-2202), a new analog of thyrotropin-releasing hormone, in plasma by radioimmunoassay. Terauchi Y; Ishikawa S; Oida S; Negoro T; Kagemoto A; Sekine Y J Pharmacobiodyn; 1988 Jun; 11(6):459-64. PubMed ID: 3139860 [TBL] [Abstract][Full Text] [Related]
40. Various types of thyrotropin-releasing hormone receptors in discrete brain regions and the pituitary of the rat. Funatsu K; Teshima S; Inanaga K J Neurochem; 1985 Aug; 45(2):390-7. PubMed ID: 2989427 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]